Nevro Corp. (NVRO) financial statements (2021 and earlier)

Company profile

Business Address 1800 BRIDGE PARKWAY
REDWOOD CITY, CA 94065
State of Incorp.
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments588573562248238233234
Cash and cash equivalents45119277136654963
Short-term investments543454286111172183171
Receivables78795765837167
Inventory, net of allowances, customer advances and progress billings83849293929192
Inventory83849293929192
Other undisclosed current assets47681067
Total current assets:753742717414422401401
Noncurrent Assets
Operating lease, right-of-use asset18192021222223
Property, plant and equipment14121111121212
Restricted cash and investments1111111
Other noncurrent assets44414131212
Total noncurrent assets:36363646484747
TOTAL ASSETS:789778753460470448448
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities66695357676563
Accounts payable23241920162023
Accrued liabilities43443437514540
Debt169167164    
Other liabilities4444443
Total current liabilities:23923922161716866
Noncurrent Liabilities
Long-term debt and lease obligation158157156182181180178
Long-term debt, excluding current maturities142140137162160158156
Operating lease, liability17181920202122
Liabilities, other than long-term debt3222222
Other liabilities3222222
Total noncurrent liabilities:162159158184183181180
Total liabilities:401399379245253250246
Stockholders' equity
Stockholders' equity attributable to parent388380374215216198202
Common stock0000000
Additional paid in capital881865851651626595580
Accumulated other comprehensive income (loss)10(1)(1)(0)(1)(1)
Accumulated deficit(493)(486)(476)(435)(410)(396)(378)
Total stockholders' equity:388380374215216198202
TOTAL LIABILITIES AND EQUITY:789778753460470448448

Income statement (P&L) ($ in millions)

12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
Revenues110108568711410094
Cost of revenue
(Cost of Goods and Services Sold)
(32)(32)(21)(27)(33)(30)(30)
Gross profit:78763561817064
Operating expenses(79)(80)(71)(84)(93)(86)(91)
Operating loss:(1)(4)(35)(23)(12)(16)(27)
Nonoperating income1001112
Investment income, nonoperating0111121
Other nonoperating income (expense)0(0)(0)0(0)(0)0
Interest and debt expense(6)(6)(6)(3)(3)(3)(3)
Loss from continuing operations before income taxes:(7)(10)(41)(25)(13)(17)(28)
Income tax expense(0)(0)(0)(0)(0)(0)(0)
Net loss available to common stockholders, diluted:(7)(10)(41)(25)(14)(18)(28)

Comprehensive Income ($ in millions)

12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
Net loss:(7)(10)(41)(25)(14)(18)(28)
Comprehensive loss:(7)(10)(41)(25)(14)(18)(28)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent111(1)00(0)
Comprehensive loss, net of tax, attributable to parent:(7)(9)(40)(26)(14)(18)(28)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: